Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2023-09-29 Report Publication Anno…
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
MODALITES DE MISE A DISPOSITION DU RAPPORT SEMESTRIEL 2023
Report Publication Announcement Classification · 1% confidence The document is titled "MODALITES DE MISE A DISPOSITION DU RAPPORT SEMESTRIEL 2023" (Modalities for making the 2023 Semi-Annual Report available). It explicitly states that the company has made its semi-annual financial report for the period ending June 30, 2023, available to the public and filed it with the AMF. The document itself is very short (2892 characters) and serves only to announce the publication and location of the actual report, rather than containing the comprehensive financial data of the report itself. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a document announces the release of another report, adhering to the 'MENU VS MEAL' rule.
2023-09-29 French
Résultats semestriels 2023Résultats semestriels 2023
Earnings Release Classification · 1% confidence The document is titled "Résultats semestriels 2023" (Half-year results 2023) and explicitly states that METabolic EXplorer (METEX) is publishing its consolidated half-year results as of June 30, 2023. It contains detailed financial tables, including the consolidated income statement ("Etat du résultat consolidé") for the first half of 2023 compared to the first half of 2022, covering revenue, EBITDA, operating result, and net result. This content structure is characteristic of a comprehensive interim financial report, which corresponds to the Interim / Quarterly Report definition (IR). It is not merely an earnings release (ER) as it includes detailed balance sheet analysis and full income statement annexes, nor is it the Annual Report (10-K) as it covers a six-month period. H1 2023
2023-09-28 French
Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/08/2023
Regulatory Filings Classification · 1% confidence The document is a formal declaration of the total number of voting rights and shares in the capital stock as of a specific date (31/08/2023), citing Article 223-16 of the AMF General Regulation. This is a standard regulatory disclosure requirement for listed companies in France regarding share capital structure and voting rights, which falls under the category of general regulatory announcements.
2023-09-05 French
Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/07/2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Déclaration du nombre total de Droits de Vote et d'Actions au capital social le 31/07/2023' (Declaration of the total number of Voting Rights and Shares in the share capital as of 07/31/2023) and explicitly references Article 223-16 of the AMF general regulation. It provides a breakdown of total shares, theoretical voting rights, self-held shares, and exercisable voting rights. This content directly relates to the official results of shareholder votes or the total voting structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category.
2023-09-05 French
Chiffre d''affaires consolidé du 1er semestre 2023
Earnings Release Classification · 1% confidence The document is a press release dated July 27, 2023, announcing the consolidated revenue ('chiffre d'affaires consolidé') for the 2nd quarter and the first half (S1) of 2023. It provides key financial figures (M€) for specialties and commodities, compares them to the previous year, and discusses business strategy adjustments. This format, focusing on period-specific financial highlights released before a comprehensive report, aligns perfectly with the definition of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it explicitly mentions the upcoming 'Résultats du 1er semestre 2023' on September 28th, suggesting this document is the initial, high-level announcement. H1 2023
2023-07-27 French
Franchissement de seuil
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to 'Declaration of crossing a threshold (Article L. 233-7 of the Commercial Code)'. This type of filing in France specifically reports changes in significant share ownership or voting rights thresholds by an investor or entity. Reviewing the provided definitions, the category 'Major Shareholding Notification' (Code: MRQ) best fits this description, as it covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The document details how SPI - Société de Projets Industriels, represented by Bpifrance Investissement, crossed the 25% voting rights threshold.
2023-07-19 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.